Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Updated on: December 21,2023

Camizestrant may be superior to fulvestrant in patients with hormone receptor-positive, HER2-negative breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe next-generation selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, compar

Updated on:December 21,2023

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on: December 20,2023

Investigating quality of life in those with large B-cell lymphoma

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainPatient-reported outcomes from individuals diagnosed with relapsed or refractory large B-cell lymphoma revealed that tho

Updated on:December 20,2023

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Updated on: December 27,2023

Scientists reveal a potential new approach to treating liver cancer

byNational Institutes of Healtha, Schematic of drug screening and validation studies; MoA, mechanism of action.b, Graphs of the results from the small-molecule screen with the MIPE library

Updated on:December 27,2023

Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-care

byWileyCredit: Unsplash/CC0 Public DomainSince the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, surv

Updated on: August 27,2024

Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-care

byWileyCredit: Unsplash/CC0 Public DomainSince the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, surv

Updated on:August 27,2024

An anticancer drug opens a new path for the treatment of Parkinson's

by Spanish National Research CouncilGraphical abstract. Credit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2024.01.007Once they enter the body, drugs, apart from carrying out

Updated on: May 21,2024

An anticancer drug opens a new path for the treatment of Parkinson's

by Spanish National Research CouncilGraphical abstract. Credit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2024.01.007Once they enter the body, drugs, apart from carrying out

Updated on:May 21,2024

Developing a promising new cancer therapy based on natural killer cells

byAlbert Einstein College of MedicineLeft shows the tumor-cell protein PVR binding with the NK-cell receptor KIR2DL5 to prevent NK-cell attack. Right, monoclonal antibody short-circuits tumor ce

Updated on: December 26,2023

Developing a promising new cancer therapy based on natural killer cells

byAlbert Einstein College of MedicineLeft shows the tumor-cell protein PVR binding with the NK-cell receptor KIR2DL5 to prevent NK-cell attack. Right, monoclonal antibody short-circuits tumor ce

Updated on:December 26,2023

Patients and doctors agree on treatment goals only half the time, says study of patients with neuroendocrine tumors

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research from cancer research and treatment organization City of Hope in the December 2022 issue ofJournal of the Na

Updated on: December 20,2023

Patients and doctors agree on treatment goals only half the time, says study of patients with neuroendocrine tumors

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research from cancer research and treatment organization City of Hope in the December 2022 issue ofJournal of the Na

Updated on:December 20,2023

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on: December 23,2023

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on:December 23,2023

Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

byBrigham and Women's HospitalScientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic. Shah’s team engineered living tumor cells using

Updated on: December 27,2023

Scientists develop a cancer vaccine to simultaneously kill and prevent brain cancer

byBrigham and Women's HospitalScientists developed a bifunctional therapeutic strategy by transforming living tumor cells into a therapeutic. Shah’s team engineered living tumor cells using

Updated on:December 27,2023

Findings of large clinical trial may have major implications for treatment of small-cell lung cancer

by SUNY Upstate Medical UniversityCredit: Pixabay/CC0 Public DomainA clinical trial led by Upstate Medical University radiation oncologist Dr. Jeffrey Bogart may have major implications for the treatm

Updated on: December 20,2023

Findings of large clinical trial may have major implications for treatment of small-cell lung cancer

by SUNY Upstate Medical UniversityCredit: Pixabay/CC0 Public DomainA clinical trial led by Upstate Medical University radiation oncologist Dr. Jeffrey Bogart may have major implications for the treatm

Updated on:December 20,2023

Financial impacts of cancer found to intensify disease burden among German patients

byEuropean Society for Medical OncologyA study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the

Updated on: December 18,2023

Financial impacts of cancer found to intensify disease burden among German patients

byEuropean Society for Medical OncologyA study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe too, and not only in the context of the

Updated on:December 18,2023

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on: June 15,2025

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on:June 15,2025